Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Strandlife
    strandlife
    • May 2013
    • 67

    #1

    Webinar on 31 Mar-Integrated Analysis using Metadata Framework & Correlation Analysis

    Live webinar on Integrated Analysis using Metadata Framework and Correlation Analysis in GeneSpring 13 - Glioblastoma case study

    Presented by Agilent Technologies and Strand Life Sciences

    Abstract
    Agilent Technologies GeneSpring® offers an intuitive and interactive environment for integrated analysis of transcriptomics, metabolomics, proteomics and NGS data within a biological context. This ability is now further enhanced by introduction of metadata framework and correlation analysis in GeneSpring 13.

    Metadata analysis framework allows researchers to visualize the abundance profiles of samples alongside metadata such as clinical, physiological, or technology related information. Ideal for large datasets, metadata framework enables users to reveal tacit dependencies between characteristics of the subjects or samples and their gene, metabolite, or protein expression profiles. Correlation, on the other hand, is a statistical technique and measures the strength and directionality of linear relationship between two quantitative variables.

    In this webinar, using the expression values, copy number and associated metadata for 173 Glioblastoma Multiforme (GBM) samples from TCGA, we will highlight and demonstrate the metadata framework and correlation functionality of GeneSpring. Specifically, we will focus on:
    • Identification of molecular subtypes in tumor samples using clustering and correlation analysis
    • Relationship between molecular subtypes and copy number aberrations using metadata analysis framework
    • Correlation analysis between mRNA and micro-RNA expression

    Speakers:
    Dr. Durairaj Renu, Senior Applications Scientist, Strand Life Sciences
    Dr. Carolina Livi, Bioinformatics Segment Manager, Agilent Technologies

    Date and sessions
    Session 1: Mar 31, 2015; SAPK/APFO; 9 PM PDT
    Session 2: Apr 1, 2015; EMEA; 7 AM PDT
    Session 3: Apr 2, 2015; AFO; 9 AM PDT

    Register at: http://www.strand-ngs.com/webinar_registration

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    Yesterday, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 02:55 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Working...